16 results on '"Rakusa, Martin"'
Search Results
2. Vpliv ozelenjenih fasad na zaznavanje urbanih okolij – primerjava med Slovenijo in Nizozemsko
- Author
-
KOZAMERNIK, Jana, RAKUŠA, Martin, and NIKŠIČ, Matej
- Published
- 2020
3. The COVID‐19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics.
- Author
-
Rakusa, Martin, Moro, Elena, Akhvlediani, Tamar, Bereczki, Daniel, Bodini, Benedetta, Cavallieri, Francesco, Fanciulli, Alessandra, Filipović, Saša R., Guekht, Alla, Helbok, Raimund, Hochmeister, Sonja, Martinelli Boneschi, Filippo, Özturk, Serefnur, Priori, Alberto, Romoli, Michele, Willekens, Barbara, Zedde, Marialuisa, and Sellner, Johann
- Subjects
- *
MEDICAL personnel , *COVID-19 pandemic , *MEDICAL economics , *NEUROLOGISTS , *MEDICAL education , *AUTONOMIC nervous system - Abstract
Background and Purpose: The COVID‐19 pandemic has significantly impacted health systems worldwide. Here, we assessed the pandemic's impact on clinical service, curricular training, and financial burden from a neurological viewpoint during the enforced lockdown periods and the assumed recovery by 2023. Methods: An online 18‐item survey was conducted by the European Academy of Neurology (EAN) NeuroCOVID‐19 Task Force among the EAN community. The survey was online between February and March 2023. Questions related to general, demographic, clinical, work, education, and economic aspects. Results: We collected 430 responses from 79 countries. Most health care professionals were aged 35–44 years, with >15 years of work experience. The key findings of their observations were as follows. (i) Clinical services were cut back in all neurological subspecialties during the most restrictive COVID‐19 lockdown period. The most affected neurological subspecialties were services for patients with dementia, and neuromuscular and movement disorders. The levels of reduction and the pace of recovery were distinct for acute emergencies and in‐ and outpatient care. Recovery was slow for sleep medicine, autonomic nervous system disorders, neurorehabilitation, and dementia care. (ii) Student and residency rotations and grand rounds were reorganized, and congresses were converted into a virtual format. Conferences are partly maintained in a hybrid format. (iii) Affordability of neurological care and medication shortage are emerging issues. Conclusions: Recovery of neurological services up to spring 2023 has been incomplete following substantial disruption of neurological care, medical education, and health economics in the wake of the COVID‐19 pandemic. The continued limitations for the delivery of neurological care threaten brain health and call for action on a global scale. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective.
- Author
-
Bassetti, Claudio L. A., Soffietti, Riccardo, Vodušek, David B., Schoser, Benedikt, Kuks, Jan B. M., Rakusa, Martin, Cras, Patrick, and Boon, Paul A. J. M.
- Subjects
SCIENCE education ,NEUROLOGY ,CLINICAL competence ,TWENTIETH century ,NEUROPHYSIOLOGY - Abstract
Background and purpose: Neurology residency programmes, which were first established at the beginning of the 20th century, have become mandatory all over Europe in the last 40–50 years. The first European Training Requirements in Neurology (ETRN) were published in 2005 and first updated in 2016. This paper reports the most recent revisions of the ETRN. Methods: Members of the EAN board performed an in depth revision of the ETNR 2016‐version, which was reviewed by members of the European Board and Section of Neurology of the UEMS, the Education and Scientific Panels, the Resident and Research Fellow Section and the Board of the EAN, as well as the presidents of the 47 European National Societies. Results: The new (2022) ETRN suggest a 5‐year training subdivided in three phases: a first phase (2 years) of general neurology training, a second phase (2 years) of training in neurophysiology/neurological subspecialties and a third phase (1 year) to expand clinical training (e.g., in other neurodisciplines) or for research (path for clinical neuroscientist). The necessary theoretical and clinical competences as well as learning objectives in diagnostic tests have been updated, are newly organized in four levels and include 19 neurological subspecialties. Finally, the new ETRN require, in addition to a programme director, a team of clinician‐educators who regularly review the resident's progress. The 2022 update of the ETRN reflects emerging requirements for the practice of neurology and contributes to the international standardization of training necessary for the increasing needs of residents and specialists across Europe. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids
- Author
-
Rakusa, Martin, primary, Chataway, Jeremy, additional, and Hardy, Todd A., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial—BLOSSOM
- Author
-
Rakusa, Martin, primary, Marolt, Iris, additional, Stevic, Zorica, additional, Rebrina, Sandra Vuckovic, additional, Milenkovic, Tatjana, additional, and Stepien, Adam, additional
- Published
- 2023
- Full Text
- View/download PDF
7. Traumatic Brain Injury during the SARS-CoV-2 Pandemics in Slovenia: A Single Center Study
- Author
-
Laufer, Kevin, primary, Petek, Karina, additional, Rakusa, Sofia, additional, Rakusa, Matej, additional, Rakusa, Martin, additional, and Cretnik, Andrej, additional
- Published
- 2022
- Full Text
- View/download PDF
8. The Importance of Subjective Cognitive Decline Recognition and the Potential of Molecular and Neurophysiological Biomarkers—A Systematic Review.
- Author
-
Ulbl, Janina and Rakusa, Martin
- Subjects
- *
MOLECULAR recognition , *NEUROPHYSIOLOGY , *COGNITION disorders , *MILD cognitive impairment , *EVOKED potentials (Electrophysiology) , *ENTERPRISE resource planning , *ALZHEIMER'S disease - Abstract
Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) are early stages of Alzheimer's disease (AD). Neurophysiological markers such as electroencephalography (EEG) and event-related potential (ERP) are emerging as alternatives to traditional molecular and imaging markers. This paper aimed to review the literature on EEG and ERP markers in individuals with SCD. We analysed 30 studies that met our criteria, with 17 focusing on resting-state or cognitive task EEG, 11 on ERPs, and two on both EEG and ERP parameters. Typical spectral changes were indicative of EEG rhythm slowing and were associated with faster clinical progression, lower education levels, and abnormal cerebrospinal fluid biomarkers profiles. Some studies found no difference in ERP components between SCD subjects, controls, or MCI, while others reported lower amplitudes in the SCD group compared to controls. Further research is needed to explore the prognostic value of EEG and ERP in relation to molecular markers in individuals with SCD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Brain Dynamics Underlying Preserved Cycling Ability in Patients With Parkinson’s Disease and Freezing of Gait
- Author
-
Licen, Teja, Rakusa, Martin, Bohnen, Nicolaas I., Manganotti, Paolo, and Marusic, Uros
- Subjects
cycling ,Parkinsonova bolezen ,udc:616.858:796.01 ,beta območje ,Parkinson's disease ,zamrznitev hoje ,kolesarjenje ,beta band ,Kortikalne oscilacije ,gait ,cortical oscillations ,General Psychology ,freezing of gait - Abstract
Parkinson’s disease (PD) is generally associated with abnormally increased beta band oscillations in the cortico-basal ganglia loop during walking. PD patients with freezing of gait (FOG) exhibit a more distinct, prolonged narrow band of beta oscillations that are locked to the initiation of movement at ∼18 Hz. Upon initiation of cycling movements, this oscillation has been reported to be weaker and rather brief in duration. Due to the suppression of the overall beta band power during cycling and its continuous nature of the movement, cycling is considered to be less demanding for cortical networks compared to walking, including reduced need for sensorimotor processing, and thus unimpaired continuous cycling motion. Furthermore, cycling has been considered one of the most efficient non-pharmacological therapies with an influence on the subthalamic nucleus (STN) beta rhythms implicative of the deep brain stimulation effects. In the current review, we provide an overview of the currently available studies and discuss the underlying mechanism of preserved cycling ability in relation to the FOG in PD patients. The mechanisms are presented in detail using a graphical scheme comparing cortical oscillations during walking and cycling in PD.
- Published
- 2022
10. The European Academy of Neurology COVID‐19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID‐19
- Author
-
Beghi, Ettore, Helbok, Raimund, Crean, Michael, Chou, Sherry Hsiang‐Yi, McNett, Molly, Moro, Elena, Bassetti, Claudio, Jenkins, Tom, Oertzen, Tim, Bodini, Benedetta, Marcerollo, Antonella, Rakusa, Martin, Soffietti, Riccardo, Oreja‐Guevara, Celia, Bereczki, Daniel, Ozturk, Serefnur, Pisani, Antonio, Sellner, Johann, Taba, Pille, Diliberto, Giovanni, Leys, Didier, Sauerbier, Anna, Cavallieri, Francesco, Priori, Alberto, and Zedde, Marialuisa
- Subjects
Adult ,medicine.medical_specialty ,Neurology ,complications ,Coronavirus disease 2019 (COVID-19) ,Clinical Neurology ,registry ,SARS‐CoV‐2 ,03 medical and health sciences ,0302 clinical medicine ,COVID‐19 ,Informed consent ,Pandemic ,medicine ,Humans ,In patient ,Registries ,030212 general & internal medicine ,Pandemics ,SARS-CoV-2 ,business.industry ,Incidence (epidemiology) ,Public health ,COVID-19 ,Neurointensive care ,Original Articles ,EAN ,neurological diseases ,outcome ,Emergency medicine ,Original Article ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
The COVID‐19 pandemic is a global public health issue. Neurological complications have been reported in up to one‐third of affected cases, but their distribution varies significantly in terms of prevalence, incidence and phenotypical characteristics. Variability can be mostly explained by the differing sources of cases (hospital vs. community‐based), the accuracy of the diagnostic approach, and the interpretation of the patients’ complaints. Moreover, after recovering, patients can still experience neurological symptoms. To obtain a more precise picture of the neurological manifestations and outcome of the COVID‐19 infection, an international registry (ENERGY) has been created by the European Academy of Neurology (EAN) in collaboration with European national neurological societies and the Neurocritical Care Society and Research Network (NCRN). ENERGY can be implemented as a stand‐alone instrument for patients with suspected or confirmed COVID‐19 patients AND neurological findings or as an addendum to an existing registry not targeting neurologic symptoms. Data are also collected to study the impact of neurological symptoms and neurological complications on outcomes. The variables included in the registry have been selected in the interest of most countries, to favour pooling with data from other sources, and to facilitate data collection even in resource‐poor countries. Included are adults with suspected or confirmed COVID‐19 infection, ascertained through neurological consultation, and providing informed consent. Key demographic and clinical findings are collected at registration. Patients are followed up to 12 months in search of incident neurological manifestations. As of August 19, 254 centres from 69 countries and four continents have made requests to join the study.
- Published
- 2021
11. COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper
- Author
-
Rakusa, Martin, Öztürk, Serefnur, Moro, Elena, Helbok, Raimund, Bassetti, Claudio L, Beghi, Ettore, Bereczki, Daniel, Bodini, Benedetta, Di Liberto, Giovanni, Jenkins, Thomas M, Macerollo, Antonella, Maia, Luis F, Martinelli-Boneschi, Filippo, Pisani, Antonio, Priori, Alberto, Sauerbier, Anna, Soffietti, Riccardo, Taba, Pille, von Oertzen, Tim J, Zedde, Marialuisa, Crean, Michael, Burlica, Anja, Cavallieri, Francesco, and Sellner, Johann
- Subjects
advocacy ,COVID-19 Vaccines ,SARS-CoV-2 ,neurological disorders ,Vaccination ,COVID-19 ,610 Medicine & health ,infectious disease prevention ,vaccination ,vaccine skepticism ,Humans ,Pandemics ,Nervous System Diseases ,Vaccination Hesitancy ,Post-Acute COVID-19 Syndrome ,Neurology ,Settore MED/26 - Neurologia ,Neurology (clinical) ,610 Medizin und Gesundheit - Abstract
BACKGROUND Health risks associated with SARS-CoV-2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe and fatal COVID-19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID-19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID-19 pandemic but puts individual lives at risk as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID-19 course. AIM In this position paper, the NeuroCOVID-19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage and formulates strategies to overcome vaccination hesitancy. A survey among the task force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation. RESULTS The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS-CoV-2 vaccination. The prevailing concerns included the chance of worsening the pre-existing neurological condition, vaccination-related adverse events, and drug interaction. RECOMMENDATIONS The EAN NeuroCOVID-19 task force reinforces the key role of neurologists as advocates of COVID-19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID-19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, their concerns and the emergence of potential safety signals.
- Published
- 2022
12. Cognitive Impairment in People with Epilepsy
- Author
-
Novak, Ajda, primary, Vizjak, Karmen, additional, and Rakusa, Martin, additional
- Published
- 2022
- Full Text
- View/download PDF
13. A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses
- Author
-
Rakusa, Martin, primary, Cano, Stefan J., additional, Porter, Bernadette, additional, Riazi, Afsane, additional, Thompson, Alan J., additional, Chataway, Jeremy, additional, and Hardy, Todd A., additional
- Published
- 2015
- Full Text
- View/download PDF
14. Management of patients with neurological diseases considering post‐pandemic coronavirus disease 2019 (COVID‐19) related risks and dangers — An updated European Academy of Neurology consensus statement.
- Author
-
Filipović, Saša R., Özturk, Serefnur, Bereczki, Daniel, Bodini, Benedetta, Cavallieri, Francesco, Fanciulli, Alessandra, Guekht, Alla, Helbok, Raimund, Hochmeister, Sonja, Martinelli Boneschi, Filippo, Priori, Alberto, Rakusa, Martin, Romoli, Michele, Willekens, Barbara, Zedde, Marialuisa, Sellner, Johann, and Moro, Elena
- Subjects
- *
COVID-19 , *NEUROLOGICAL disorders , *VACCINATION complications , *MULTIPLE sclerosis , *TASK forces - Abstract
Background and purpose Methods Results Conclusion In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the coronavirus disease 2019 (COVID‐19) pandemic was published. Due to important changes and developments that have happened since then, the need has arisen to critically reassess the original recommendations and address new challenges.In step 1, the original items were critically reviewed by the EAN COVID‐19 Task Force. In addition, new recommendations were defined. In step 2, an online survey with the recommendations forged in step 1 was sent to the Managing Groups of all Scientific and Coordinating Panels of EAN. In step 3, the final set of recommendations was made.In step 1, out of the original 36 recommendations, 18 were judged still relevant. They were edited to reflect the advances in knowledge and practice. In addition, 21 new recommendations were formulated to address the new knowledge and challenges. In step 2, out of the 39 recommendations sent for the survey, nine were approved as they were, whilst suggestions for improvement were given for the rest. In step 3, the recommendations were further edited, and some new items were formed to accommodate the participants' suggestions, resulting in a final set of 41 recommendations.This revision of the 2020 EAN Statement provides updated comprehensive and structured guidance on good clinical practice in people with neurological disease faced with SARS‐CoV‐2 infection. It now covers the issues from the more recent domains of COVID‐19‐related care, vaccine complications and post‐COVID‐19 conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. The European Academy of Neurology NeuroCOVID‐19 Task Force: A lesson for the future.
- Author
-
Cavallieri, Francesco, Sellner, Johann, Akhvlediani, Tamar, Bassetti, Claudio L., Bereczki, Daniel, Fanciulli, Alessandra, Filipović, Saša R., Guekht, Alla, Helbok, Raimund, Hochmeister, Sonja, Martinelli Boneschi, Filippo, Oertzen, Tim J., Özturk, Serefnur, Priori, Alberto, Ramankulov, Dauren, Willekens, Barbara, Rakusa, Martin, and Moro, Elena
- Abstract
Background Method Results Conclusions The COVID‐19 pandemic has made its mark on world history forever causing millions of deaths, and straining health systems, economies, and societies worldwide. The European Academy of Neurology (EAN) reacted promptly. A special NeuroCOVID‐19 Task Force was set up at the beginning of the pandemic to promote knowledge, research, international collaborations, and raise awareness about the prevention and treatment of COVID‐19‐related neurological issues.Activities carried out during and after the pandemic by the EAN NeuroCOVID‐19 Task Force are described. The main aim was to review all these initiatives in detail as an overarching lesson from the past to improve the present and be better prepared in case of future pandemics.During the pandemic, the Task Force was engaged in several initiatives: the creation of the EAN NEuro‐covid ReGistrY (ENERGY); the launch of several surveys (neurological manifestations of COVID‐19 infection; the pandemic's impact on patients with chronic neurological diseases; the pandemic's impact of restrictions for clinical practice, curricular training, and health economics); the publication of position papers regarding the management of patients with neurological diseases during the pandemic, and vaccination hesitancy among people with chronic neurological disorders; and the creation of a dedicated “COVID‐19 Breaking News” section in EANpages.The EAN NeuroCOVID‐19 Task Force was immediately engaged in various activities to participate in the fight against COVID‐19. The Task Force's concerted strategy may serve as a foundation for upcoming global neurological emergencies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Assessment of the haptic robot as a new tool for the study of the neural control of reaching
- Author
-
Blaz Koritnik, Janez Zidar, Piero Paolo Battaglni, Marko Munih, Aleš Belič, Martin Rakusa, Ales Hribar, Rakusa, Martin, Hribar, A, Koritnik, B, Munih, M, Battaglini, PIERO PAOLO, Belic, A, and Zidar, J.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Computer science ,Movement ,Combined use ,Dermatology ,Electroencephalography ,Audiology ,Event-related potential ,medicine ,Neural control ,Image Processing, Computer-Assisted ,Reaction Time ,Humans ,Cortical Synchronization ,Haptic technology ,Communication ,Brain Mapping ,medicine.diagnostic_test ,business.industry ,Brain ,haptic robot ,General Medicine ,Robotics ,Hand ,Magnetic Resonance Imaging ,reaching ,Oxygen ,Psychiatry and Mental health ,Robot ,Female ,Neurology (clinical) ,Experimental methods ,business ,Psychomotor Performance - Abstract
Current experimental methods for the study of reaching in the MRI environment do not exactly mimic actual reaching, due to constrains in movement which are imposed by the MRI machine itself. We tested a haptic robot (HR) as such a tool. Positive results would also be promising for combined use of fMRI and EEG to study reaching. Twenty right-handed subjects performed reaching tasks with their right hand with and without the HR. Reaction time, movement time (MT), accuracy, event-related potentials (ERPs) and event-related desynchronisation/synchronisation (ERD/ERS) were studied. Reaction times and accuracies did not differ significantly between the two tasks, while the MT was significantly longer in HR reaching (959 vs. 447 ms). We identified two positive and two negative ERP peaks across all leads in both tasks. The latencies of the P1 and N2 peaks were significantly longer in HR reaching, while there were no significant differences in the P3 and N4 latencies. ERD/ERS topographies were similar between tasks and similar to other reaching studies. Main difference was in ERS rebound which was observed only in actual reaching. Probable reason was significantly larger MT. We found that reaching with the HR engages similar neural structures as in actual reaching. Although there are some constrains, its use may be superior to other techniques used for reaching studies in the MRI environment, where freedom of movement is limited.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.